BiVictriX Therapeutics PLC BVX:London Stock Exchange

RT Quote | Exchange | GBp
Last | 03/27/24 GMT
11.75UNCH (UNCH)
52 week range
9.00 - 16.00
Loading...
  • Open11.75
  • Day High0.00
  • Day Low0.00
  • Prev Close11.75
  • 52 Week High16.00
  • 52 Week High Date07/25/23
  • 52 Week Low9.00
  • 52 Week Low Date01/03/24

Key Stats

  • Market Cap12.24M
  • Shares Out82.53M
  • 10 Day Average Volume2,778.33
  • Dividend-
  • Dividend Yield-
  • Beta-0.54
  • YTD % Change11.9

KEY STATS

  • Open11.75
  • Day High0.00
  • Day Low0.00
  • Prev Close11.75
  • 52 Week High16.00
  • 52 Week High Date07/25/23
  • 52 Week Low9.00
  • 52 Week Low Date01/03/24
  • Market Cap12.24M
  • Shares Out82.53M
  • 10 Day Average Volume2,778.33
  • Dividend-
  • Dividend Yield-
  • Beta-0.54
  • YTD % Change11.9

RATIOS/PROFITABILITY

  • EPS (TTM)-3.52
  • P/E (TTM)-3.34
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On BiVictriX Therapeutics PLC

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
BiVictriX Therapeutics plc is a United Kingdom-based drug discovery and development company focused on developing cancer therapeutics. The Company’s lead program, BVX001, is a Bi-Cygni antibody drug conjugate (ADC) designed to target the cancer-specific Bi-Cygni fingerprint, CD7 x CD33, found on the cancer cells of approximately 25-30% of patients with acute myeloid leukemia (AML), and in subpopulations of cancer cells from patients with other hematological cancers. The...
Address
Mereside, Alderley Park, Alderley Edge
Macclesfield
SK10 4TG
United Kingdom